Non-Hodgkin Lymphoma Secondary to Cancer Chemotherapy

Cancer Epidemiology Biomarkers and Prevention - United States
doi 10.1158/1055-9965.epi-06-1069
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Occurrence of Sarcoidosis After Chemotherapy for Non-Hodgkin Lymphoma

Korean Journal of Internal Medicine
Internal Medicine
2016English

Non-Hodgkin Lymphoma

2020English

Epidemiology of Chemotherapy-Induced Anemia in Patients With Non-Hodgkin Lymphoma

Permanente journal,The
Medicine
2019English

Polymorphic MLH1 and Risk of Cancer After Methylating Chemotherapy for Hodgkin Lymphoma

Journal of Medical Genetics
Genetics
2007English

EBV-Positive Plasmablastic Lymphoma Mimicking Reactive Lymphadenopathy Versus Recurrent Hodgkin Lymphoma Following Chemotherapy for Stage II Classical Hodgkin Lymphoma

Journal of Tumour Research & Reports
2018English

Studies Identify Non-Hodgkin Lymphoma Suppressor

Cancer Discovery
Oncology
2015English

Central Nervous System Hodgkin Lymphoma Developing During Systemic Chemotherapy

British Journal of Haematology
Hematology
2015English

Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma

Advances in Hematology
Hematology
2011English

Eruptive Pseudoangiomatosis in a Child Undergoing Chemotherapy for Hodgkin Lymphoma

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy